Clinical Trial Update: A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study [Phase 2]

View source ↗

Summary

Phase IIb study of DE-126 ophthalmic solution in open-angle glaucoma or ocular hypertension completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• DE-126 ophthalmic solution

Snippet

Sponsor: Santen Inc. | Conditions: Open-angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2020-10-23